TYRA-300 0.25 mg/kg

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of TYRA-300 in Children With Achondroplasia: BEACH301NCT06842355TYRAPhase 2Recruiting2030-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.